Townsend Richard Nolan - Insider Non-Derivative Transactions at Lexeo Therapeutics, Inc. (LXEO) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Sep 10, 2024, Townsend Richard Nolan's relationship to Lexeo Therapeutics, Inc. (LXEO) is Director,Officer (Chief Executive Officer), and currently has 125,695 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other LXEO insiders.

Data Source: SEC.
Townsend Richard Nolan - Insider Non-Derivative Transactions of LXEO Common Stock
Townsend Richard Nolan - Insider Non-Derivative Transactions at LXEO
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Sep 11, 2024 Sell -- (Common Stock) 5000 10.65 120695
Sep 11, 2024 M -- (Common Stock) 5000 2.33 125695
Aug 13, 2024 Sell -- (Common Stock) 5000 11.53 120695
Aug 13, 2024 M -- (Common Stock) 5000 2.33 125695
Jul 12, 2024 Sell -- (Common Stock) 100 19.06 120695
Jul 12, 2024 Sell -- (Common Stock) 27931 17.06 120795
Jul 11, 2024 Sell -- (Common Stock) 3347 16.85 148726
Jul 11, 2024 Sell -- (Common Stock) 23622 16.45 152073
Jul 11, 2024 M -- (Common Stock) 5000 2.33 175695
Jun 11, 2024 Sell -- (Common Stock) 2038 18.18 170695
Jun 11, 2024 Sell -- (Common Stock) 2962 17.29 172733
Jun 11, 2024 M -- (Common Stock) 5000 2.33 175695
May 14, 2024 Sell -- (Common Stock) 5000 13.22 170695
May 14, 2024 M -- (Common Stock) 5000 2.33 175695
Jan 6, 2024 Acquisition -- (Common Stock) 43750 0 170695